These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9707357)

  • 1. Drug interactions as a cause of overanticoagulation and bleedings in Chinese patients receiving warfarin.
    Chan TY
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):403-5. PubMed ID: 9707357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.
    Howard PA; Ellerbeck EF; Engelman KK; Patterson KL
    Pharmacoepidemiol Drug Saf; 2002; 11(7):569-76. PubMed ID: 12462133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of concurrent use of warfarin with potentially interacting drugs.
    Wittkowsky AK; Boccuzzi SJ; Wogen J; Wygant G; Patel P; Hauch O
    Pharmacotherapy; 2004 Dec; 24(12):1668-74. PubMed ID: 15585436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Warfarin treatment and bleeding].
    Breen AB; Vaskinn TE; Reikvam A; Skovlund E; Lislevand H; Madsen S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1835-7. PubMed ID: 12830257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin.
    Leung VW; Shalansky SJ; Lo MK; Jadusingh EA
    Ann Pharmacother; 2009 May; 43(5):875-81. PubMed ID: 19401475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapy.
    Kotirum S; Chaiyakunapruk N; Jampachaisri K; Wattanasombat S; Rojnuckarin P
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):216-22. PubMed ID: 16874847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin prevalence, indications for use and haemorrhagic events.
    Ouirke W; Cahill M; Perera K; Sargent J; Conway J
    Ir Med J; 2007 Mar; 100(3):402-4. PubMed ID: 17491542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish oil interaction with warfarin.
    Buckley MS; Goff AD; Knapp WE
    Ann Pharmacother; 2004 Jan; 38(1):50-2. PubMed ID: 14742793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline.
    Jankel CA; McMillan JA; Martin BC
    Am J Hosp Pharm; 1994 Mar; 51(5):661-6. PubMed ID: 8203385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miconazole-warfarin interaction: increased INR.
    Murty M
    CMAJ; 2001 Jul; 165(1):81-2, 85-6. PubMed ID: 11468962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Concomitant use of warfarin, analgesics and anti-inflammatory agents].
    Håkonsen GD; Pettersen MH; Skurtveit S; Giverhaug T
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1217-20. PubMed ID: 19521444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-ingestion of herbal medicines and warfarin.
    Smith L; Ernst E; PaulEwings ; Myers P; Smith C
    Br J Gen Pract; 2004 Jun; 54(503):439-41. PubMed ID: 15186565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.
    Phillips EM; Buchan DA; Newman N; Rajan A; Zia S
    Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
    Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual hypersensitivity to warfarin in a critically ill patient.
    Konishi H; Eguchi Y; Fujii M; Saotome T; Sasaki T; Takahashi K; Sudo M; Morii H; Minouchi T; Yamaji A
    J Clin Pharm Ther; 2004 Oct; 29(5):485-90. PubMed ID: 15482394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
    Parrish RH; Pazdur DE; O'donnell PJ
    Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.